Ruti Aga Gets Six Years: How a Forged Prescription Turned a Two-Year Case Into Career Death

In the March half marathon in China, Ruti Aga won the race. Her name was at the top of the field, and that was the moment the Athletics Integrity Unit's sample collection team reached her. The outcome was not what anyone in the crowd expects — methylprednisolone was found in the sample. A knee injury, a prescription written by a family member, and a clinic that did not exist. The AIU's decision on 11 September turned that victory into a disciplinary file: a six-year ban, two years for the substance and four for tampering with documents. The first thing that must be clear is technical, because the entire case rests on it. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid, class S9 of the WADA Prohibited List, and it is prohibited in-competition only — by injection, oral or rectal route. A therapeutic knee injection given out of competition is entirely legal. It becomes a violation only if residues are present in-competition. In road racing, the testing window opens at 23:59 the day before the race. That is the technical trap Aga fell into — and it is also the doorway she had left open. Covering athletics from India, I have seen this pattern many times: an athlete's real contract is not the medal but the livelihood — a Railways job, a Services quota, a state police salary. The East African road-running economy is not different, only its currency is. A marathoner's income runs on appearance fees. If the knee is bad, skipping a race costs not just one race but an agent's trust and the next invitation. That is why the instinct to mask pain goes to the fastest, cheapest remedy — a glucocorticoid injection. And that is why Chinese label races, where big fees and deep East African elite fields converge, have become the AIU's highest-yield testing ground. The real failure was not the drug, it was medical governance. The AIU's investigation found that the prescription was written by a family member — who was not a registered physician. He claimed to have used "an old prescription pad from a former workplace," and the clinic explicitly disowned any such pad. Three independent verification failures in a single document. This is not a filing error — it is the signature of an athlete operating without a credentialed team physician. A properly managed athlete has two paths: hold or apply for a Therapeutic Use Exemption, or observe the WADA route-specific washout period. Neither happened. The arithmetic of the sanction tells us what the panel concluded. Two years for presence — which usually arrives when a Specified Substance is found and intent is not proven — and four years for tampering, the Code's standard sanction. Two and four, six. That means the panel rejected the no-significant-fault mitigation that could have reduced the presence sanction. Backdating to 10 September is a procedural benefit, not a discount — provisional suspension time counts against the ban. This is where the contrarian angle sits, and the media coverage is missing it entirely. Methylprednisolone has no proven endurance benefit. So this case did not start where most doping stories start. She had a legitimate defence available — injury documentation, injection date, route, medical necessity. Intra-articular methylprednisolone for knee synovitis is standard sports-medicine practice in distance runners; its practical plausibility is exactly what makes the forgery so fatal. The moment the prescription was proven fake, that moment she lost the one defence that could have been stronger than real records. In other words: the drug gave her two years, the document gave her the other four. At 32, a six-year ban sets a return age of roughly 38. Ethiopia's women's marathon depth is so extreme that even a 2:18 performer is not automatically selected — and for a 38-year-old with a doping record the selection question is closed. Technically it is six years; functionally it is the end of a career. Her historical record will stand apart: the 2026 Tokyo Marathon title and three second places at World Marathon Majors — all three Major runner-up finishes are proof of genuine ability, and all pre-date the March race. The source does not state the scope of disqualification, but under standard AIU practice the competition where the sample was collected is automatically voided along with its prize money — a safe assumption, and no older title disappears on its own. The most uncomfortable part is that the tampering charge came not from a document but from an interview. Statements given under questioning produced contradictions, and that is where the four years attached. Language and translation conditions in AIU interviews with East African runners have been a recurring point of contention — raising the question here is fair, because in an interview-based prosecution the precision of words is the entire case. There is also a structural truth that cannot be ignored: among the East African road-running cases reaching the AIU in recent years there is a recognisable family — an initial substance violation, then a fabricated or altered explanation. The enforcement frontier has moved from "detection" to "document verification." The same informal medical networks serve many athletes in the same training cluster, so more cases of this profile are likely in the pipeline. And here is the question that turns toward agents and management, not just the athlete. The AIU statement names only the family member who wrote the prescription. Whether an agent or manager advised or accepted that document is not publicly clear. In an economy where appearance fees are the main income, accountability is pushed onto the thinnest link — and the thinnest link is often the one least able to speak. No statement from the Ethiopian federation is quoted in this case; only the AIU has spoken. That silence is itself a signal. From twenty years standing between the stadium and the depot, the most useful lesson I have learned is that an athlete's real protection does not come from her prescription but from the professional honesty of the people around her. A credentialed team doctor, a TUE file, a correct washout calendar — had those three existed, this article would never have been written. Someday Ruti Aga's story will be read not merely as a sanction but as the question that road running's entire ecosystem should be asked: when an athlete's career is caught between her pain and her agent, is the responsibility hers alone?